FINWIRES · TerminalLIVE
FINWIRES

Meta Platforms Stock Selloff Reflects Q3 Guidance, No Clarity on AI Monetization, Oppenheimer Says

By

Meta Platforms (META) stock selloff is due to a lower-than-expected Q3 revenue guide and no additional clarity on artificial intelligence monetization despite better Q2 revenue and operating income, Oppenheimer said in a research report emailed Thursday.

For the full-year 2026 and 2027, the brokerage said it now expects EPS of $30.47 and $31.69, respectively.

The brokerage said that the Street EPS for fiscal 2027 did not price in higher compute costs without a neocloud deal, limiting growth for the near future.

Oppenheimer said it reiterated its perform rating on the stock.

Price: $531.22, Change: $-54.39, Percent Change: -9.29%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT